Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors

INTRODUCTION: The molecular determinants of breast cancer resistance to first-line anthracycline-containing chemotherapy are unknown. METHODS: We examined the response to doxorubicin of organotypic cultures of primary human breast tumors ex vivo with respect to cell proliferation, DNA damage and mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Faversani, Alice, Vaira, Valentina, Moro, Giacomina P, Tosi, Delfina, Lopergolo, Alessia, Schultz, David C, Rivadeneira, Dayana, Altieri, Dario C, Bosari, Silvano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076638/
https://www.ncbi.nlm.nih.gov/pubmed/24886669
http://dx.doi.org/10.1186/bcr3666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076638/
https://www.ncbi.nlm.nih.gov/pubmed/24886669
http://dx.doi.org/10.1186/bcr3666

Ejemplares similares